Your browser doesn't support javascript.
loading
Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas.
Kovatchev, Boris P; Renard, Eric; Cobelli, Claudio; Zisser, Howard C; Keith-Hynes, Patrick; Anderson, Stacey M; Brown, Sue A; Chernavvsky, Daniel R; Breton, Marc D; Mize, Lloyd B; Farret, Anne; Place, Jérôme; Bruttomesso, Daniela; Del Favero, Simone; Boscari, Federico; Galasso, Silvia; Avogaro, Angelo; Magni, Lalo; Di Palma, Federico; Toffanin, Chiara; Messori, Mirko; Dassau, Eyal; Doyle, Francis J.
Affiliation
  • Kovatchev BP; Center for Diabetes Technology and Department of Medicine, Division of Endocrinology, University of Virginia, Charlottesville, VA boris@virginia.edu.
  • Renard E; Department of Endocrinology, Diabetes, and Nutrition, Montpellier University Hospital, INSERM Clinical Investigation Center 1001, Institute of Functional Genomics, CNRS UMR 5203, INSERM U661, University of Montpellier 1, Montpellier, France.
  • Cobelli C; Department of Information Engineering and Department of Internal Medicine, Unit of Metabolic Disease, University of Padova, Padova, Italy.
  • Zisser HC; Sansum Diabetes Research Institute, Santa Barbara, CA.
  • Keith-Hynes P; Center for Diabetes Technology and Department of Medicine, Division of Endocrinology, University of Virginia, Charlottesville, VA.
  • Anderson SM; Center for Diabetes Technology and Department of Medicine, Division of Endocrinology, University of Virginia, Charlottesville, VA.
  • Brown SA; Center for Diabetes Technology and Department of Medicine, Division of Endocrinology, University of Virginia, Charlottesville, VA.
  • Chernavvsky DR; Center for Diabetes Technology and Department of Medicine, Division of Endocrinology, University of Virginia, Charlottesville, VA.
  • Breton MD; Center for Diabetes Technology and Department of Medicine, Division of Endocrinology, University of Virginia, Charlottesville, VA.
  • Mize LB; Center for Diabetes Technology and Department of Medicine, Division of Endocrinology, University of Virginia, Charlottesville, VA.
  • Farret A; Department of Endocrinology, Diabetes, and Nutrition, Montpellier University Hospital, INSERM Clinical Investigation Center 1001, Institute of Functional Genomics, CNRS UMR 5203, INSERM U661, University of Montpellier 1, Montpellier, France.
  • Place J; Department of Endocrinology, Diabetes, and Nutrition, Montpellier University Hospital, INSERM Clinical Investigation Center 1001, Institute of Functional Genomics, CNRS UMR 5203, INSERM U661, University of Montpellier 1, Montpellier, France.
  • Bruttomesso D; Department of Information Engineering and Department of Internal Medicine, Unit of Metabolic Disease, University of Padova, Padova, Italy.
  • Del Favero S; Department of Information Engineering and Department of Internal Medicine, Unit of Metabolic Disease, University of Padova, Padova, Italy.
  • Boscari F; Department of Information Engineering and Department of Internal Medicine, Unit of Metabolic Disease, University of Padova, Padova, Italy.
  • Galasso S; Department of Information Engineering and Department of Internal Medicine, Unit of Metabolic Disease, University of Padova, Padova, Italy.
  • Avogaro A; Department of Information Engineering and Department of Internal Medicine, Unit of Metabolic Disease, University of Padova, Padova, Italy.
  • Magni L; Department of Systems Engineering, University of Pavia, Pavia, Italy.
  • Di Palma F; Department of Systems Engineering, University of Pavia, Pavia, Italy.
  • Toffanin C; Department of Systems Engineering, University of Pavia, Pavia, Italy.
  • Messori M; Department of Systems Engineering, University of Pavia, Pavia, Italy.
  • Dassau E; Department of Chemical Engineering, University of California, Santa Barbara, Santa Barbara, CA.
  • Doyle FJ; Department of Chemical Engineering, University of California, Santa Barbara, Santa Barbara, CA.
Diabetes Care ; 37(7): 1789-96, 2014 Jul.
Article in En | MEDLINE | ID: mdl-24929429

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreas, Artificial / Diabetes Mellitus, Type 1 / Hypoglycemic Agents / Insulin Type of study: Clinical_trials / Guideline Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Diabetes Care Year: 2014 Type: Article Affiliation country: Vatican City

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreas, Artificial / Diabetes Mellitus, Type 1 / Hypoglycemic Agents / Insulin Type of study: Clinical_trials / Guideline Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Diabetes Care Year: 2014 Type: Article Affiliation country: Vatican City